Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $111.14 | 8 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech USA, Inc. | $31.66 | 2 | $0 (2019) |
| Merck Sharp & Dohme LLC | $23.12 | 2 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $23.00 | 2 | $0 (2020) |
| Dexcom, Inc. | $18.97 | 1 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $14.39 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $31.13 | 2 | Dexcom, Inc. ($18.97) |
| 2020 | $11.05 | 1 | AstraZeneca Pharmaceuticals LP ($11.05) |
| 2019 | $27.46 | 2 | Janssen Pharmaceuticals, Inc ($14.39) |
| 2018 | $41.50 | 3 | Genentech USA, Inc. ($18.59) |
All Payment Transactions
8 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/05/2022 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: Endocrinology | ||||||
| 02/08/2022 | Merck Sharp & Dohme LLC | GARDASIL 9 (Biological), VAXNEUVANCE | Food and Beverage | In-kind items and services | $12.16 | General |
| Category: VACCINE | ||||||
| 07/07/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.05 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/15/2019 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: Virology & Specialty Care | ||||||
| 01/30/2019 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug), XARELTO | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/12/2018 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: Virology & Specialty Care | ||||||
| 10/31/2018 | AstraZeneca Pharmaceuticals LP | BEVESPI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $11.95 | General |
| Category: Respiratory | ||||||
| 09/05/2018 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, BELSOMRA | Food and Beverage | In-kind items and services | $10.96 | General |
| Category: ENDOCRINOLOGY | ||||||
About Dr. Bruce Storms, M.D
Dr. Bruce Storms, M.D is a Emergency Medicine healthcare provider based in Chickasha, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1124059050.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bruce Storms, M.D has received a total of $111.14 in payments from pharmaceutical and medical device companies, with $31.13 received in 2022. These payments were reported across 8 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($111.14).
Practice Information
- Specialty Emergency Medicine
- Location Chickasha, OK
- Active Since 07/06/2006
- Last Updated 02/21/2008
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1124059050
Products in Payments
- Xofluza (Drug) $31.66
- Dexcom G6 Transmitter (Medical Supply) $18.97
- INVOKANA (Drug) $14.39
- GARDASIL 9 (Biological) $12.16
- BEVESPI AEROSPHERE (Drug) $11.95
- FARXIGA (Drug) $11.05
- JANUVIA (Drug) $10.96
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.